No valuation for Dexmate is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($41.0M) and the funding record below are the closest available signals.
- ·The complete investor list: 11 names
- ·Watch Dexmate: the Monday email on marks, rounds and moves
Dexmate funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Feb 2026 | Early Stage VC | $41.0M | ▮ | ▮ |
Membership and data by Private Market View
How much has Dexmate raised?
Dexmate has raised $41 million across 1 recorded round since 2026. The largest was a $41 million early-stage round in Feb 2026.
Dexmate has filed 1 Form D with the SEC, most recently in Mar 2026 ($41 million sold to 29 investors).
How Dexmate's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Dexmate, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about Dexmate
- How much has Dexmate raised?
- Dexmate has raised $41.0M in total funding across 1 recorded rounds.
- When did Dexmate last raise?
- Dexmate last raised in Feb 2026 (Early Stage VC), raising $41.0M.